Bringing the fundamentals into focus…
Back to Jazz Pharmaceuticals plc
How Jazz Pharmaceuticals plc stacks up
JAZZ · against 121 other Healthcare companies of similar size
Growth
80/ 100
Above the middle of the pack.
Ranked #29 of 122 · scores higher than 74% of peers
Bars: peers in each 10-point band of the growth score19 peers with a growth score of 80–89, including JAZZ · Click a bar to see the companies
Why growth scores 80?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings per share growth and revenue growth, which are stronger than most Healthcare peers.
- 3-year revenue growth is close to the peer norm. 3-year revenue growth: 6.9% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 67% of peers. Revenue growth: 12.6% vs peer median 6.1%
- Earnings per share turned from a loss to a profit. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = JAZZ, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | JAZZ | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 123 reported | 12.6% | 9.5% | 59% | 33% | |
| Earnings per share growthHigher is better · 88 reported | Not reported | 18.3% | — | — | 33% |
| 3-year revenue growthHigher is better · 117 reported | 6.9% | 10.5% | 42% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around JAZZ| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 9.3B USD | 98 | 64 | |
| 3 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 3 | 21.4B USD | 97 | 67 | |
| 5 | 16.5B USD | 96 | 37 | |
| 25 | 9.1B USD | 83 | 74 | |
| 27 | 23.5B USD | 82 | 27 | |
| 27 | 23.8B USD | 82 | 84 | |
| 29 | 14.6B USD | 80 | 59 | |
| 29 | 14.9B USD | 80 | 65 | |
| 29 | 9.0B USD | 80 | 78 | |
| 29 | 921.9B INR (≈$11.1B) | 80 | 82 | |
| 29 | 10.1B USD | 80 | 61 | |
| 34 | 13.7B USD | 79 | 45 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score